학술논문

Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders
Document Type
Journal
Source
EUROPEAN JOURNAL OF NEUROLOGY; JUN 2023, 30 p413-p414, 2p. Supplement: 1
Subject
Language
English
ISSN
14681331